← SynDRA
LY2109761
SynDRA canonical compound SYN1953727 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Primary target(s) | TGFBR1 | TGFBR2 |
| Mechanism of action | TGF beta receptor inhibitor |
All known targets
Mechanisms of action (all sources)
- TGF beta receptor inhibitor
- TGFBR1 INHIBITOR
- TGFBR2 INHIBITOR
Cross-references
Synonyms
- LY 2109761
- LY-2109761
- 4-(2-((4-(2-(Pyridin-2-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl)quinolin-7-yl)oxy)ethyl)morpholine
- DV3HD37UBK
- 4-(5,6-Dihydro-2-(2-pyridinyl)-4H-pyrrolo(1,2-b)pyrazol-3-yl)-7-(2-(4-morpholinyl)ethoxy)quinoline
- 4-[5,6-Dihydro-2-(2-pyridinyl)-4H-pyrrolo[1,2-b]pyrazol-3-yl]-7-[2-(4-morpholinyl)ethoxy]quinoline
- Quinoline, 4-(5,6-dihydro-2-(2-pyridinyl)-4H-pyrrolo(1,2-b)pyrazol-3-yl)-7-(2-(4-morpholinyl)ethoxy)-
- Quinoline, 4-[5,6-dihydro-2-(2-pyridinyl)-4H-pyrrolo[1,2-b]pyrazol-3-yl]-7-[2-(4-morpholinyl)ethoxy]-
- UNII-DV3HD37UBK
- Dihydropyrrolopyrazole, 15d
- MLS006010968
- CHEMBL260015
- GTPL8075
- SCHEMBL3737735
- BDBM21509
- DTXSID30470111
- EX-A071
- HMS3674E17
- AMY24227
- BCP02824
- MFCD12923354
- NSC765632
- s2704
- ZINC14976393
- AKOS022183732
- BCP9000868
- CCG-269143
- CS-0571
- NSC-765632
- SB19481
- NCGC00242598-01
- NCGC00242598-03
- NCGC00242598-10
- AC-30289
- AS-56101
- HY-12075
- SMR004702772
- FT-0698866
- J-514249
Look up LY2109761 in the interactive SynDRA portal →